These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 12776013

  • 1. A guide to device selection: cardiac resynchronization therapy alone or in combination with an implantable cardioverter defibrillator.
    Prystowsky EN.
    Rev Cardiovasc Med; 2003; 4 Suppl 2():S47-54. PubMed ID: 12776013
    [Abstract] [Full Text] [Related]

  • 2. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
    Prystowsky EN.
    Rev Cardiovasc Med; 2001; 2(4):197-205. PubMed ID: 12439369
    [Abstract] [Full Text] [Related]

  • 3. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW, Griffith MJ, Pathmanathan RK, Ng GA, Clune MM, Cooper J, Marshall HJ, Forsey PR, Stafford PJ, Gray RG, Skehan JD, Garratt CJ.
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [Abstract] [Full Text] [Related]

  • 4. [Primary prevention of sudden cardiac death implanted cardioverter defibrillator (ICD) versus antiarrhythmic drugs].
    Iturralde Torres P.
    Arch Cardiol Mex; 2007 Jul; 77 Suppl 4():S4-129-32. PubMed ID: 18938711
    [Abstract] [Full Text] [Related]

  • 5. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS.
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [Abstract] [Full Text] [Related]

  • 6. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
    Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH.
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
    [Abstract] [Full Text] [Related]

  • 7. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, Schofield RS, Sears SF, Aranda JM.
    J Am Coll Cardiol; 2009 Nov 24; 54(22):1993-2000. PubMed ID: 19926003
    [Abstract] [Full Text] [Related]

  • 8. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW, Lee HJ, Kao CW, Friedmann E, Thomas SA, Anderson J, Bardy GH.
    Am J Crit Care; 2008 Sep 24; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [Abstract] [Full Text] [Related]

  • 9. Antiarrhythmic therapy in heart failure.
    Eckardt L, Haverkamp W, Breithardt G.
    Heart Fail Monit; 2002 Sep 24; 2(4):110-9. PubMed ID: 12634885
    [Abstract] [Full Text] [Related]

  • 10. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M.
    Expert Rev Cardiovasc Ther; 2009 Feb 24; 7(2):181-95. PubMed ID: 19210214
    [Abstract] [Full Text] [Related]

  • 11. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL, Dual Chamber and VVI Implantable Defibrillator trial investigators.
    Card Electrophysiol Rev; 2003 Dec 24; 7(4):468-72. PubMed ID: 15071277
    [Abstract] [Full Text] [Related]

  • 12. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Freudenberger RS, Hellkamp AS, Halperin JL, Poole J, Anderson J, Johnson G, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Circulation; 2007 May 22; 115(20):2637-41. PubMed ID: 17485579
    [Abstract] [Full Text] [Related]

  • 13. Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials.
    Piccini JP, Berger JS, O'Connor CM.
    Eur Heart J; 2009 May 22; 30(10):1245-53. PubMed ID: 19336434
    [Abstract] [Full Text] [Related]

  • 14. Ventricular tachycardia and sudden cardiac death.
    Reddy PC, Tandon N, Stafford PR.
    J La State Med Soc; 1999 May 22; 151(5):281-7. PubMed ID: 10363484
    [Abstract] [Full Text] [Related]

  • 15. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L, Hua W, Niu H, Chen K, Zhang S.
    Europace; 2008 Sep 22; 10(9):1034-41. PubMed ID: 18559335
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.
    Arch Intern Med; 2009 Sep 14; 169(16):1500-6. PubMed ID: 19752408
    [Abstract] [Full Text] [Related]

  • 17. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS, Zehender M.
    Ther Umsch; 2000 May 14; 57(5):324-32. PubMed ID: 10859993
    [Abstract] [Full Text] [Related]

  • 18. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH, Gold MR.
    Cardiol Clin; 2008 Aug 14; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [Abstract] [Full Text] [Related]

  • 19. Role of drugs and devices in patients at risk of sudden cardiac death.
    Boriani G, Diemberger I, Valzania C, Biffi M, Martignani C, Raschi E, Mantovani V, Ziacchi M, Bertini M, De Ponti F, Branzi A.
    Fundam Clin Pharmacol; 2010 Oct 14; 24(5):575-94. PubMed ID: 20608989
    [Abstract] [Full Text] [Related]

  • 20. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F.
    J Cardiovasc Med (Hagerstown); 2007 Apr 14; 8(4):293-9. PubMed ID: 17413310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.